Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

5.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.1K
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

338
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
338

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cryptococcal Meningitis: Comparison of Short- (≤ 1 Week) Versus Longer-duration (> 1 Week) Liposomal Amphotericin B Induction Therapy and Factors Associated With Clinical Outcomes in HIV and Non-HIV Patients.

Open forum infectious diseases·2026
Same author

Increasing threat to the healthcare setting: Candida auris.

Current opinion in infectious diseases·2026
Same author

Telework and Employee Well-Being During the COVID-19 Pandemic: A Two-Wave Survey of Employees at a Texas Health Sciences University.

Archivos de prevencion de riesgos laborales·2026
Same author

Closing the gap on antifungal resistance.

Nature medicine·2026
Same author

Candida glabrata emerges as the most common cause of candidemia: analysis of a large hospital-based database, United States, 2016-2024.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Exploring Early Antifungal Activity of Rezafungin as a Stepping-Stone for Shorter Treatment Duration for Candidemia: Pooled Analysis of 2 Randomized Trials.

Open forum infectious diseases·2026
Same journal

Monographic Issue on New Concepts in Acute Exacerbations of COPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Bidirectional Clinical Interactions among Exacerbations and Comorbidities in COPD: A Narrative Review.

Seminars in respiratory and critical care medicine·2026
Same journal

Radiological Approach to Severe Respiratory Infections and Pulmonary Complications in Immunocompromised Patients.

Seminars in respiratory and critical care medicine·2026
Same journal

Two Sides of the Same Smoke: Decoding Respiratory Bronchiolitis-Associated Interstitial Lung Disease and Alveolar Macrophage Pneumonia.

Seminars in respiratory and critical care medicine·2026
Same journal

Role of Vaccination in the Prevention of ECOPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives.

Seminars in respiratory and critical care medicine·2026
See all related articles

Related Experiment Video

Updated: Dec 29, 2025

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
03:24

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging

Published on: March 22, 2024

2.0K

Invasive Candidiasis.

María F Gonzalez-Lara1, Luis Ostrosky-Zeichner2

  • 1Clinical Microbiology Laboratory, Infectious Diseases Department, Instituto Nacional de Ciencias Médica y Nutrición Salvador Zubirán, Mexico City, Mexico.

Seminars in Respiratory and Critical Care Medicine
|January 31, 2020
PubMed
Summary
This summary is machine-generated.

Invasive candidiasis (IC), a common healthcare-associated fungal infection, presents diagnostic challenges. Early echinocandin treatment is recommended, with new antifungal agents in development for resistant strains like Candida auris.

More Related Videos

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

7.3K
A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
06:50

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms

Published on: September 16, 2022

3.5K

Related Experiment Videos

Last Updated: Dec 29, 2025

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
03:24

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging

Published on: March 22, 2024

2.0K
Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

7.3K
A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
06:50

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms

Published on: September 16, 2022

3.5K

Area of Science:

  • Infectious Diseases
  • Mycology
  • Critical Care Medicine

Background:

  • Invasive candidiasis (IC) is a prevalent, severe healthcare-associated fungal infection.
  • Candida albicans is the primary cause, but non-albicans species, including multidrug-resistant Candida auris, are increasing.
  • IC leads to significant morbidity, mortality, and healthcare costs.

Purpose of the Study:

  • To review the current landscape of invasive candidiasis.
  • To highlight diagnostic challenges and emerging resistance patterns.
  • To discuss current and future therapeutic strategies.

Main Methods:

  • Review of current literature on invasive candidiasis.
  • Analysis of epidemiological trends and etiological agents.
  • Evaluation of diagnostic biomarkers and molecular methods.
  • Assessment of current and emerging antifungal treatments.

Main Results:

  • Invasive candidiasis presents a spectrum from fungemia to septic shock.
  • Non-albicans Candida species, particularly Candida auris, show increasing prevalence and antifungal resistance.
  • Diagnosis remains challenging, necessitating improved biomarkers and molecular techniques.

Conclusions:

  • Early echinocandin therapy is the preferred initial treatment for IC.
  • Antifungal susceptibility testing guides step-down therapy.
  • New antifungal agents are under development to combat resistant strains and improve patient outcomes.